Terry is a professor in the Department of Pharmacology and Therapeutics at McGill University. His research focuses on GPCR signalling in the cardiovascular system. He is interested in developing translational training for medical students, undergraduate students, and graduate students. Not only is Terry a driving force behind the scenes for rareDIG, but he is also involved in curriculum development in the undergraduate medical program and strives to learn something new about medical education every day.
Dr. Terry Hebert
Kyle started his pediatric residency training at the University of Ottawa this year. He holds a BSc in Biochemistry and an MSc in Neuroscience - his thesis investigated a novel pharmcotherapeutic strategy for amyotrophic lateral sclerosis. Kyle was introduced to rare diseases through his work with pediatric patient populations, inspiring him to help with the founding of rareDIG in 2017. He hopes to continue advocating for individuals with rare disease throughout his residency training and beyond.